TRLPC: Concordia concessions show pharmaceutical loans under pressure

NEW YORK, Oct 21 (Reuters) - Banks arranging a US$1.865bn-equivalent of leveraged acquisition loans for US pharmaceutical company Concordia Healthcare had to offer heavy discounts and other concessions to attract investors as this part of the US healthcare sector continues to be pummelled.